{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Hemodynamic Adverse Effects of Dexmedetomidine and Propofol in a Critically Ill Trauma and Surgical Population: A Retrospective Cohort

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the hemodynamic adverse effects (AEs) and the incidence of those AEs experienced by critically ill trauma and surgical patients receiving either dexmedetomidine or propofol.
  2. Evaluate the type and frequency of interventions required for hemodynamic AEs between dexmedetomidine and propofol groups in a critically ill trauma and surgical population.
Price: $24.95


  • ANCC 2.5 CH / 2.5 APH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: JTN0521A
Published: May/Jun 2021
Expires: 6/2/2023
Required Passing Score: 7/10 (70%)
Authors: Carli R. Nicholson, PharmD; Chanda Mullen, PhD; Lawrence A. Frazee, PharmD, BCPS; Michaelia D. Cucci, PharmD, BCPS, BCCCP